微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2.79% | -28.46% | -50.18% | 34/157 | 0.06% | 泽璟制药 | 44.02% | 行业排名> |
| 2025-12-31 | 5.6% | -52.05% | -6.04% | 55/157 | -4.46% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-09-30 | 5.96% | -41.63% | 33.63% | 53/157 | 1.31% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-06-30 | 4.46% | -30.2% | 14.36% | 38/157 | 0.3% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-03-31 | 3.9% | 6.27% | -66.61% | 20/157 | -0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2024-12-31 | 11.68% | 61.33% | 14.4% | 21/157 | -9.62% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-09-30 | 10.21% | 57.32% | 59.78% | 24/157 | 4.28% | 百利天恒 | 181.27% | 行业排名> |
| 2024-06-30 | 6.39% | 82.05% | 74.11% | 24/157 | 2.69% | 百利天恒 | 186.1% | 行业排名> |
| 2024-03-31 | 3.67% | 32.01% | -49.31% | 21/157 | 2.35% | 百利天恒 | 186.89% | 行业排名> |
| 2023-12-31 | 7.24% | 23.76% | 11.56% | 45/157 | -1% | 百利天恒 | 188.56% | 行业排名> |
| 2023-09-30 | 6.49% | 63.07% | 84.9% | 50/157 | 2.36% | 小方制药 | 41.8% | 行业排名> |
| 2023-06-30 | 3.51% | 24.91% | 26.26% | 61/157 | 1.48% | 拓新药业 | 20.51% | 行业排名> |
| 2023-03-31 | 2.78% | 7.75% | -52.48% | 41/157 | 1.37% | 拓新药业 | 19.87% | 行业排名> |
| 2022-12-31 | 5.85% | -1.18% | 46.98% | 67/157 | 0.79% | 拓新药业 | 19.91% | 行业排名> |
| 2022-09-30 | 3.98% | -69.71% | 41.64% | 72/157 | 2.86% | 小方制药 | 55.57% | 行业排名> |
| 2022-06-30 | 2.81% | -48.72% | 8.91% | 71/157 | 2.21% | 福元医药 | 25.41% | 行业排名> |
| 2022-03-31 | 2.58% | 9.79% | -56.42% | 48/157 | 1.59% | 小方制药 | 34.81% | 行业排名> |
| 2021-12-31 | 5.92% | 137% | -54.95% | 72/157 | 0.84% | 退市金泰 | 10.74% | 行业排名> |
| 2021-09-30 | 13.14% | 307.26% | 139.78% | 13/157 | 4.46% | ST人福 | 6.82% | 行业排名> |
| 2021-06-30 | 5.48% | 168.07% | 133.19% | 50/157 | 2.99% | 小方制药 | 71.99% | 行业排名> |
| 2021-03-31 | 2.35% | 166.57% | 114.69% | 57/157 | 2.49% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | -16% | -7519.05% | -152.37% | 123/157 | 3.8% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-09-30 | -6.34% | -8025% | 21.24% | 108/157 | 3.13% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | -8.05% | -533.86% | -128.05% | 121/157 | 4.28% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-03-31 | -3.53% | -34.73% | -1580.95% | 104/157 | 2.23% | 中哲精化 | 45.32% | 行业排名> |
| 2019-12-31 | -0.21% | -105.54% | -362.5% | 115/157 | 2.57% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-09-30 | 0.08% | -97.84% | 106.3% | 98/157 | 7.58% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-06-30 | -1.27% | -130.68% | 51.53% | 108/157 | 5.02% | 奥赛康 | 35% | 行业排名> |
| 2019-03-31 | -2.62% | -232.99% | -169.13% | 103/157 | 2.45% | 奥赛康 | 28.15% | 行业排名> |
| 2018-12-31 | 3.79% | -5.01% | 2.16% | 98/157 | 7.16% | 宏源药业 | 21.91% | 行业排名> |
| 2018-09-30 | 3.71% | 3.34% | -10.39% | 79/157 | 7.21% | 奥赛康 | 9.7% | 行业排名> |
| 2018-06-30 | 4.14% | 1.72% | 110.15% | 53/157 | 4.63% | 奥赛康 | 40.69% | 行业排名> |
| 2018-03-31 | 1.97% | 207.81% | -50.63% | 54/157 | 2.57% | 信立泰 | 25.93% | 行业排名> |
| 2017-12-31 | 3.99% | -58.26% | 11.14% | 91/157 | 9.62% | 昂利康 | 15.91% | 行业排名> |
| 2017-09-30 | 3.59% | -56.75% | -11.79% | 68/157 | 8.31% | 奥赛康 | 12.08% | 行业排名> |
| 2017-06-30 | 4.07% | -12.85% | 535.94% | 60/157 | 5.56% | 一品红 | 31.62% | 行业排名> |
| 2017-03-31 | 0.64% | -52.94% | -93.31% | 71/157 | 2.1% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 9.56% | 39.97% | 15.18% | 58/157 | 6.05% | 中哲精化 | 54.24% | 行业排名> |
| 2016-09-30 | 8.3% | 54.28% | 77.73% | 34/157 | 5.64% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 4.67% | 10.4% | 243.38% | 42/157 | 3.52% | ST南新 | 81.7% | 行业排名> |
| 2016-03-31 | 1.36% | -29.53% | -80.09% | 53/157 | 2.69% | 德展健康 | 29.5% | 行业排名> |